Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
NuPulseCV, Inc. is actively prosecuting a patent portfolio in the Medical Devices & Mechanical Engineering technology area. The portfolio currently has 3 pending office actions, which define the current level of activity for the company. These actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution suggests a varied technical or procedural scope, as the company is navigating multiple points of review within the USPTO simultaneously.
The busiest examiner for NuPulseCV, Inc. is GHAND, JENNIFER LEIGH-STEWAR, who is responsible for the busiest examiner pending office actions. This means that while the portfolio is spread across multiple examiners, a significant portion of the current workload is concentrated with a specific individual. This structure requires the company to manage different examination styles while focusing its resources on the specific requirements of the busiest examiner within the Medical Devices & Mechanical Engineering sector. The presence of the distinct art units further indicates the administrative footprint for NuPulseCV, Inc.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GHAND, JENNIFER LEIGH-STEWAR | 2 | 60.5% | +27.8% |
| HUH, VYNN V | 1 | 62.2% | +44.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17944127 | INTRA-AORTIC BALLOON PUMP ASSEMBLY | GHAND, JENNIFER LEIGH-STEWAR | 119d overdue |
| 17944130 | INTRA-AORTIC BALLOON PUMP ASSEMBLY WITH PRESSURE SENSOR | HUH, VYNN V | 21d |
| 17944125 | BLOOD PUMP SUPPORT APPARATUS AND METHOD FOR A BLOOD PUMP ASSEMBLY | GHAND, JENNIFER LEIGH-STEWAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17944127 | INTRA-AORTIC BALLOON PUMP ASSEMBLY | GHAND, JENNIFER LEIGH-STEWAR | 119d overdue |
| 17944130 | INTRA-AORTIC BALLOON PUMP ASSEMBLY WITH PRESSURE SENSOR | HUH, VYNN V | 21d |
| 17944125 | BLOOD PUMP SUPPORT APPARATUS AND METHOD FOR A BLOOD PUMP ASSEMBLY | GHAND, JENNIFER LEIGH-STEWAR | — |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17944127 | INTRA-AORTIC BALLOON PUMP ASSEMBLY | GHAND, JENNIFER LEIGH-STEWAR | 3796 | §103§112 | Non-Final OA | 119d overdue | Pending | Sep 13, 2022 |
| 17944125 | BLOOD PUMP SUPPORT APPARATUS AND METHOD FOR A BLOOD PUMP ASSEMBLY | GHAND, JENNIFER LEIGH-STEWAR | 3796 | §102§103§112 | Non-Final OA | — | Pending | Sep 13, 2022 |
| 17944130 | INTRA-AORTIC BALLOON PUMP ASSEMBLY WITH PRESSURE SENSOR | HUH, VYNN V | 3792 | §102§103§112 | Non-Final OA | 21d | Pending | Sep 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial